NCT02533583

Brief Summary

The investigator assessed the feasibility and reliability of pulse oximetry plus clinical observation for detection the lung disease in neonates.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2015

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 4, 2015

Completed
23 days until next milestone

First Posted

Study publicly available on registry

August 27, 2015

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2015

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

August 12, 2016

Status Verified

August 1, 2016

Enrollment Period

1 year

First QC Date

August 4, 2015

Last Update Submit

August 11, 2016

Conditions

Keywords

pulse oximetryclinical assessmentneonatelung disease

Outcome Measures

Primary Outcomes (1)

  • pulse oximetry with clinical observation screen lung disease sensitivity

    use wilson method to calculate the sensitivity

    7 days

Secondary Outcomes (2)

  • pulse oximetry with clinical observation screen lung disease specificity

    7 days

  • pulse oximetry with clinical observation screen lung disease positive and negative value

    7 days

Study Arms (2)

symptomatic newborn

the symptomatic newborn cohort( symptomatic definition see detail),all of babies will referred for chest X-ray,and within 2 hours performing echocardiography to exclude critical and serious heart disease.All clinical assessment will do by attending doctor.

Device: pulse oximetry (PHILIPS intelliven MP5)

Asymptomatic newborn

the asymptomatic newborn cohort will gave pulse oximetry and clinical assessment every 8 hours within 3 days.everybody have positive results will been preformed chest X-ray and echocardiography.All clinical assessment will do by attending doctor.

Device: pulse oximetry (PHILIPS intelliven MP5)

Interventions

all newborn monitor pulse oximetry in left hand

Also known as: PHILIPS intelliven MP5
Asymptomatic newbornsymptomatic newborn

Eligibility Criteria

Age1 Day - 3 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

All infants will born in guangdong women and children hospital

You may qualify if:

  • gestation age :28 to 42 weeks
  • birth weight :1000-4000g
  • asymptomatic or symptomatic respiratory symptom

You may not qualify if:

  • gestation age \<28 weeks or \>42 weeks
  • birth weight \<1000g or \>4000g
  • critical and serious heart disease
  • congenital malformation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Zhao QM, Ma XJ, Ge XL, Liu F, Yan WL, Wu L, Ye M, Liang XC, Zhang J, Gao Y, Jia B, Huang GY; Neonatal Congenital Heart Disease screening group. Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: a prospective study. Lancet. 2014 Aug 30;384(9945):747-54. doi: 10.1016/S0140-6736(14)60198-7. Epub 2014 Apr 22.

    PMID: 24768155BACKGROUND
  • Iyer NP, Baumann A, Rzeszotarski MS, Ferguson RD, Mhanna MJ. Radiation exposure in extremely low birth weight infants during their neonatal intensive care unit stay. World J Pediatr. 2013 May;9(2):175-8. doi: 10.1007/s12519-013-0417-1. Epub 2013 May 16.

    PMID: 23677834BACKGROUND
  • Bahadue FL, Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2012 Nov 14;11(11):CD001456. doi: 10.1002/14651858.CD001456.pub2.

    PMID: 23152207BACKGROUND

MeSH Terms

Conditions

Lung Diseases

Interventions

Oximetry

Condition Hierarchy (Ancestors)

Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Blood Gas AnalysisBlood Chemical AnalysisClinical Chemistry TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisHeart Function TestsDiagnostic Techniques, CardiovascularRespiratory Function TestsDiagnostic Techniques, Respiratory SystemInvestigative Techniques

Study Officials

  • jie yang, doctor

    Guangdong Women and Children Hospital

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

August 4, 2015

First Posted

August 27, 2015

Study Start

November 1, 2015

Primary Completion

November 1, 2016

Study Completion

December 1, 2016

Last Updated

August 12, 2016

Record last verified: 2016-08